Sagiment Biosciences【SGMT】株式ニュース

名称	銘柄コード	市場	種別
Sagiment Biosciences Inc	SGMT	NASDAQ	普通株式

	前日比	前日比 %	現在値	時刻
	0.30	6.26%	5.09	06:52:50

始値	安値	高値	終値	前日終値
4.77	4.66	5.20	5.08	4.79

この銘柄の詳細情報 »

最新ニュース

日付	時間	ソース	タイトル
2024/5/15	21:05	EDGAR2	Form 8-K - Current report
2024/5/15	20:00	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/5/09	05:06	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/5/09	05:05	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/5/06	21:06	EDGAR2	Form 8-K - Current report
2024/3/25	20:00	GLOBE	Sagimet Biosciences Announces Appointment of Tim Walbert and..
2024/3/25	19:15	GLOBE	Sagimet Biosciences Reports Full Year 2023 Financial Results..
2024/2/29	22:00	GLOBE	Sagimet Biosciences to Participate in Two Upcoming Investor..
2024/2/15	08:10	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/15	06:37	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/06	06:34	EDGAR2	Form SC 13G - Statement of acquisition of beneficial..
2024/2/03	06:36	EDGAR2	Form 8-K - Current report
2024/2/03	06:05	EDGAR2	Form 3 - Initial statement of beneficial ownership of..
2024/2/01	06:56	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/2/01	06:55	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2024/1/31	06:05	EDGAR2	Form 8-K - Current report
2024/1/26	14:15	EDGAR2	Form EFFECT - Notice of Effectiveness
2024/1/26	10:58	GLOBE	Sagimet Biosciences Announces Pricing of Public Offering of..
2024/1/24	20:10	EDGAR2	Form 8-K - Current report
2024/1/24	20:08	EDGAR2	Form S-1/A - General form for registration of securities..
2024/1/24	07:45	GLOBE	Sagimet Biosciences Announces Proposed Public Offering of..
2024/1/24	07:31	EDGAR2	Form S-1 - General form for registration of securities under..
2024/1/22	22:00	EDGAR2	Form 8-K - Current report
2024/1/22	21:00	GLOBE	Sagimet Biosciences Announces Positive Topline Results from..
2023/12/30	06:16	EDGAR2	Form 8-K - Current report
2023/12/09	06:05	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/12/04	22:00	GLOBE	Sagimet Biosciences to Participate in the First Annual..
2023/11/28	22:00	GLOBE	Sagimet Biosciences Announces Oral Presentation of..
2023/11/22	22:00	GLOBE	Sagimet Biosciences to Present at the 35th Annual Piper..
2023/11/22	06:22	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/22	06:21	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/21	11:59	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/11/13	22:40	EDGAR2	Form 8-K - Current report
2023/11/13	22:31	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/11/13	22:00	GLOBE	Sagimet Biosciences Reports Third Quarter 2023 Financial..
2023/11/10	22:30	GLOBE	Sagimet Biosciences Presents Preclinical Results Supporting..
2023/10/25	00:00	GLOBE	Sagimet Biosciences Announces Acceptance of Two Abstracts at..
2023/10/23	21:00	EDGAR2	Form 8-K - Current report
2023/10/19	05:05	GLOBE	Sagimet Biosciences To Present at the H.C. Wainwright 7th..
2023/9/28	05:32	EDGAR2	Form 8-K - Current report
2023/9/28	05:05	GLOBE	Sagimet Biosciences Announces Completion of Enrollment of..
2023/9/09	05:15	EDGAR2	Form 4 - Statement of changes in beneficial ownership of..
2023/8/22	05:09	EDGAR2	Form 8-K - Current report
2023/8/22	05:05	EDGAR2	Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2023/8/22	05:02	GLOBE	Sagimet Biosciences Reports Second Quarter 2023 Financial..
2023/8/16	05:04	GLOBE	Sagimet Biosciences Announces Closing of Underwriters’..
2023/8/10	21:14	EDGAR2	Form 8-K - Current report
2023/7/21	05:05	GLOBE	Sagimet Biosciences Announces Leadership Changes
2023/7/14	10:10	GLOBE	Sagimet Biosciences Announces Pricing of Upsized Initial..
2023/6/23	15:30	GLOBE	Sagimet Biosciences Presents Positive Phase 2b FASCINATE-2..